Evidence Database - access research on nutrition and mental health

Evidence database

Access our database of research on nutrition and mental health

FDA Decision on Dementia Drug, Aducanumab

Today, the US FDA has licenced aducanumab, an amyloid protein drug developed for dementia treatment. It has already failed in clinical trials, adding to the 300 studies that have failed. In a…